pharmadog

News

when

Latest
Archive

by source

All Sources
Sources Page

Jobs

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

made by humans and a good dog

home
jobs
news
search

calendar

18,993 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

hide past →

sort

soonest latest type sponsor alpha

type: filing×type: approval×clear all

type

approval18,987
phase readout7,208
device 510k5,000
grant4,728
8k filing3,603
device pma2,000
device recall

2,000

recall1,126

device adverse event1,000

earnings585

therapy area

Ophthalmology5

Week of Mar 2, 2026

›Mar 6, 2026approval176d agoSOTYKTU (DEUCRAVACITINIB) — FDA approvalBristol-Myers Squibb Co

Sponsor: BRISTOL. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Mar 6, 2026approval176d agoTROKENDI XR (TOPIRAMATE) — FDA approvalSUPERNUS PHARMACEUTICALS, INC.

Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

›Mar 6, 2026approval176d agoNICARDIPINE HYDROCHLORIDE — FDA approvalNICARDIPINE HYDROCHLORIDE

Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

full page →NICARDIPINE HYDROCHLORIDE →fda approvals ↗

›Mar 6, 2026approval176d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: PRINSTON INC. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

›Mar 6, 2026approval176d agoEVEROLIMUS — FDA approvalEVEROLIMUS

Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

full page →EVEROLIMUS →fda approvals ↗

›Mar 6, 2026approval176d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION

full page →Restasis →fda approvals ↗

›Mar 6, 2026approval176d agoEPRONTIA (TOPIRAMATE) — FDA approvaltopiramate ER

Sponsor: AZURITY. Form: SOLUTION. Route: ORAL

full page →topiramate ER →fda approvals ↗

›Mar 6, 2026approval176d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL

full page →Restasis →fda approvals ↗

›Mar 6, 2026approval176d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

Sponsor: PFIZER. Form: SOLUTION. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Week of Mar 9, 2026

›Mar 9, 2026approval173d agoOXCARBAZEPINE — FDA approvalRiconpharma LLC

Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗

›Mar 9, 2026approval

← prev

page 371 of 380

173d ago

ATROPINE SULFATE — FDA approvalATROPINE SULFATE

Sponsor: APOTEX. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →ATROPINE SULFATE →fda approvals ↗

›Mar 9, 2026approval173d agoBISOPROLOL FUMARATE — FDA approvalBISOPROLOL FUMARATE

Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

full page →BISOPROLOL FUMARATE →fda approvals ↗

›Mar 9, 2026approval173d agoSODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (SODIUM CHLORIDE) — FDA approvalRevalesio Corp

Sponsor: B BRAUN. Form: SOLUTION. Route: IRRIGATION

full page →fda approvals ↗

›Mar 9, 2026approval173d agoFAMOTIDINE — FDA approvalKenvue Inc.

Sponsor: CONTRACT PHARMACAL. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

›Mar 9, 2026approval173d agoIVERMECTIN — FDA approvalMedinCell SA

Sponsor: E5 PHARMA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Mar 9, 2026approval173d agoWELLCOVORIN (LEUCOVORIN CALCIUM) — FDA approvalLEUCOVORIN CALCIUM

Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

full page →LEUCOVORIN CALCIUM →fda approvals ↗

›Mar 9, 2026approval173d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: KNACK. Form: INJECTABLE. Route: INJECTION

full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗

›Mar 9, 2026approval173d agoQUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: NEXTWAVE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

›Mar 10, 2026approval172d agoKARBINAL ER (CARBINOXAMINE MALEATE) — FDA approvalAYTU BIOPHARMA, INC

Sponsor: AYTU. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

›Mar 10, 2026approval172d agoARCALYST (RILONACEPT) — FDA approvalrilonacept

Sponsor: KINIKSA PHARMACEUTICALS (UK), LTD.. Form: VIAL. Route: SINGLE-USE

full page →rilonacept →fda approvals ↗

›Mar 10, 2026approval172d agoQUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: NEXTWAVE PHARMS. Form: TABLET, EXTENDED RELEASE, CHEWABLE. Route: ORAL

full page →fda approvals ↗

›Mar 10, 2026approval172d agoDESVENLAFAXINE SUCCINATE — FDA approvaldesvenlafaxine succinate ER

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →desvenlafaxine succinate ER →fda approvals ↗

›Mar 10, 2026approval172d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

Sponsor: INNOGENIX. Form: TABLET. Route: ORAL

full page →METRONIDAZOLE →fda approvals ↗

›Mar 10, 2026approval172d agoDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalDoxil

Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION

full page →Doxil →fda approvals ↗

›Mar 10, 2026approval172d agoALEVE (NAPROXEN SODIUM) — FDA approvalNAPROXEN SODIUM

Sponsor: BAYER. Form: TABLET. Route: ORAL

full page →NAPROXEN SODIUM →fda approvals ↗

›Mar 10, 2026approval172d agoADAPALENE — FDA approvalPL Developments Copiague LLC

Sponsor: P AND L. Form: GEL. Route: TOPICAL

full page →fda approvals ↗

›Mar 10, 2026approval172d agoOGSIVEO (NIROGACESTAT HYDROBROMIDE) — FDA approvalnirogacestat hydrobromide

Sponsor: SPRINGWORKS. Form: TABLET. Route: ORAL

full page →nirogacestat hydrobromide →fda approvals ↗

›Mar 10, 2026approval172d agoMESALAMINE — FDA approvalDifGen Pharmaceuticals LLC

Sponsor: DIFGEN PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

›Mar 11, 2026approval171d agoLABETALOL HYDROCHLORIDE — FDA approvalHikma Pharmaceuticals USA Inc

Sponsor: HIBROW HLTHCARE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Mar 11, 2026approval171d agoTESTOSTERONE — FDA approvalTransdermal Delivery Solutions Corp

Sponsor: ENCUBE. Form: GEL, METERED. Route: TRANSDERMAL

full page →fda approvals ↗

›Mar 11, 2026approval171d agoDOXYCYCLINE — FDA approvaldoxycycline ER

Sponsor: STRIDES PHARMA INTL. Form: CAPSULE. Route: ORAL

full page →doxycycline ER →fda approvals ↗

›Mar 11, 2026approval171d agoCEVIMELINE HYDROCHLORIDE — FDA approvalCEVIMELINE HYDROCHLORIDE

Sponsor: ZYDUS LIFESCIENCES. Form: CAPSULE. Route: ORAL

full page →CEVIMELINE HYDROCHLORIDE →fda approvals ↗

›Mar 11, 2026approval171d agoLIRAGLUTIDE — FDA approvalSaxenda

Sponsor: BIOCON PHARMA. Form: SOLUTION. Route: SUBCUTANEOUS

full page →Saxenda →fda approvals ↗

›Mar 11, 2026approval171d agoOMEPRAZOLE — FDA approvalomeprazole DR

Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL

full page →omeprazole DR →fda approvals ↗

›Mar 11, 2026approval171d agoSODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (SODIUM CHLORIDE) — FDA approvalRevalesio Corp

Sponsor: LABORATORIOS GRIFOLS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Mar 11, 2026approval171d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →choline fenofibrate →fda approvals ↗

›Mar 11, 2026approval171d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →choline fenofibrate →fda approvals ↗

›Mar 11, 2026approval171d agoOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

full page →dexamethasone LA →fda approvals ↗

›Mar 11, 2026approval171d agoLANSOPRAZOLE — FDA approvallansoprazole DR

Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL

full page →lansoprazole DR →fda approvals ↗

›Mar 11, 2026approval171d agoFERRIC CITRATE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Mar 11, 2026approval171d agoMEROPENEM — FDA approvalMEROPENEM

Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

full page →MEROPENEM →fda approvals ↗

›Mar 11, 2026approval171d agoMEROPENEM — FDA approvalMEROPENEM

Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

full page →MEROPENEM →fda approvals ↗

›Mar 11, 2026approval171d agoMEROPENEM — FDA approvalMEROPENEM

Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

full page →MEROPENEM →fda approvals ↗

›Mar 11, 2026approval171d agoLINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Mar 11, 2026approval171d agoAPHEXDA (MOTIXAFORTIDE ACETATE) — FDA approvalBioLineRx Ltd.

Sponsor: AYRMID PHARMA. Form: POWDER. Route: SUBCUTANEOUS

full page →fda approvals ↗

›Mar 11, 2026approval171d agoBRIMONIDINE TARTRATE — FDA approvalLumify

Sponsor: GLAND. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Lumify →fda approvals ↗

›Mar 12, 2026approval170d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Mar 12, 2026approval170d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Mar 12, 2026approval170d agoPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (DEXTROMETHORPHAN HYDROBROMIDE) — FDA approvalPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE

Sponsor: HETERO LABS LTD III. Form: SYRUP. Route: ORAL

full page →PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE →fda approvals ↗

›Mar 12, 2026approval170d agoTRULICITY (DULAGLUTIDE) — FDA approvaldulaglutide

Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION

full page →dulaglutide →fda approvals ↗

$NVS153.81-0.54%

$PFE27.96-0.21%

$SUPN44.19-1.54%

$NVS153.81-0.54%

$AMRX17.54-2.61%

$COLL26.44-3.89%

$KVUE19.20-0.10%

$AYTU2.2300-0.89%

$ABBV255.48-1.03%

$BLRX2.6000-8.77%

$NVS153.81-0.54%

$LLY1174.61-0.13%

$NVS153.81-0.54%